▼ SELL
$ Value
$751K
Shares
8,643
Price
$87
Filed
Nov 17
Insider
Name
Walsh Patrick D
Title
—
CIK
0001720568
Roles
Director
Transaction Details
Transaction Date
2025-11-13
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
61,405
Footnotes
The shares were sold in multiple trades at prices ranging from $86.15 to $87.80. The price reported above reflects the weighted average sales price. | This transaction reported on this Form 4 reflects a bona fide gift of Company's common stock to a donor-advised fund ("DAF") for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.
Filing Info
Walsh Patrick D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | ANIP | ▼ | $445K |
| 2025-11-13 | ANIP | ▼ | $751K |
| 2025-11-13 | ANIP | G | $0 |
| 2025-08-15 | ANIP | ▼ | $801K |
| 2025-05-22 | ANIP | A | $0 |
Other Insiders at ANIP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
|
— | $357K | 2026-03-11 |
|
CAREY STEPHEN P.
SVP & CFO
|
— | $552K | 2026-03-07 |
| Walsh Patrick D | — | $445K | 2026-03-03 |
|
Lalwani Nikhil
PRESIDENT & CEO
|
— | — | 2026-03-07 |
|
Gutwerg Ori
SVP, GENERICS
|
— | $158K | 2026-03-07 |
|
Mutz Christopher
HEAD OF RARE DISEASE
|
— | $1.6M | 2026-03-13 |
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
|
— | — | 2026-02-26 |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
|
— | — | 2026-02-28 |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
|
— | $114K | 2026-04-13 |
|
Davis Krista
SVP, CHIEF HR OFFICER
|
— | $785K | 2026-03-09 |